Invasive Candidiasis Management in ICU

Primary Recommendations

• The Infectious Diseases Society of America (IDSA) recommends micafungin 100 mg IV daily as the preferred empiric therapy for suspected or confirmed invasive candidiasis in nonneutropenic ICU patients, with equal efficacy to other echinocandins and superior outcomes compared to azole-based therapy in critically ill populations 1, 2

First-Line Empiric Therapy

• The IDSA provides a strong recommendation with moderate-quality evidence for echinocandins as preferred empiric therapy in ICU patients 1, 4
• Start empiric antifungal therapy in ICU patients with sepsis who have multiple risk factors: Candida colonization at multiple sites, broad-spectrum antibiotic exposure, central venous catheters, total parenteral nutrition, recent major surgery, necrotizing pancreatitis, dialysis, or corticosteroid use 1, 4

Essential Adjunctive Measures

• Remove central venous catheters in all nonneutropenic patients with candidemia—this is mandatory, not optional 1, 4, 3
• Perform surgical intervention for intra-abdominal candidiasis in addition to antifungal therapy 2

Duration of Therapy

• Continue treatment for minimum 2 weeks after documented clearance of Candida from bloodstream AND resolution of attributable signs and symptoms 1, 2, 3
• Discontinue empiric antifungal therapy at 4-5 days if no clinical response, no subsequent evidence of invasive candidiasis, and negative non-culture-based diagnostic assay with high negative predictive value 1

Critical Pitfalls to Avoid

• Never delay appropriate antifungal therapy in septic shock—mortality approaches 100% without timely treatment and source control 2, 4
• Do not discontinue therapy prematurely—complete the full 2 weeks after blood culture clearance to prevent relapse 2, 3
• Do not switch to fluconazole before confirming species identification and susceptibility testing, especially in critically ill patients 2, 3

Prophylaxis Considerations

• In ICUs with invasive candidiasis rates >5%, consider fluconazole 800 mg loading then 400 mg daily for high-risk patients 1
• Alternatively, use echinocandin prophylaxis (micafungin 100 mg daily) in high-incidence units 1
• Daily chlorhexidine bathing decreases bloodstream infections including candidemia 1, 4